Globus Medical (GMED) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Total Assets Chart for Globus Medical

Globus Medical (GMED) total assets for FY2025 were USD 5.3B, a 1.0% change from FY2024. Globus Medical's total assets grew from USD 266.6M in 2010 to USD 5.3B in 2025 (1889.2% over 15 years). Total assets compound annual growth rate: 5-year CAGR of 25.9%, 10-year CAGR of 20.3%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$10.26B
Implied Share Price
$91.76
Enterprise Value
$9.45B
Revenue (TTM)
$3.14B
EBITDA
$1.01B
Profit Margin
17.03%
Trailing P/E
19.60
Forward P/E
13.87
Price/Book (MRQ)
2.08
Price/Sales (TTM)
3.26
EV/EBITDA
9.90
EV/Revenue
3.00
Dividend Yield
—
Book Value
$35.52
Free Cash Flow (FY2025)
$588.77M
Free Cash Flow Yield
5.74%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.